Sean Matchett, DO - Medicare Osteopathic Manipulative Medicine in Camden, NJ

Sean Matchett, DO is a medicare enrolled "Hospitalist" physician in Camden, New Jersey. He graduated from medical school in 2017 and has 7 years of diverse experience with area of expertise as Osteopathic Manipulative Medicine. He is a member of the group practice Cooper Physician Offices Pa and his current practice location is 1 Cooper Plz, Camden, New Jersey. You can reach out to his office (for appointments etc.) via phone at (856) 342-2000.

Sean Matchett is licensed to practice in New Jersey (license number 25MB10812500) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1295261287.

Contact Information

Sean Matchett, DO
1 Cooper Plz,
Camden, NJ 08103-1461
(856) 342-2000
Not Available



Physician's Profile

Full NameSean Matchett
GenderMale
SpecialityOsteopathic Manipulative Medicine
Experience7 Years
Location1 Cooper Plz, Camden, New Jersey
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Sean Matchett graduated from medical school in 2017
  NPI Data:
  • NPI Number: 1295261287
  • Provider Enumeration Date: 05/11/2017
  • Last Update Date: 07/28/2020
  Medicare PECOS Information:
  • PECOS PAC ID: 1254695729
  • Enrollment ID: I20200909000576

Medical Identifiers

Medical identifiers for Sean Matchett such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1295261287NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208M00000XHospitalist 25MB10812500 (New Jersey)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Inspira Medical Center ElmerElmer, NJHospital
Inspira Medical Center VinelandVineland, NJHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Cooper Physician Offices Pa2860396611241

News Archive

Mathematical model to help answer critical questions to large-scale anthrax exposure

If terrorists targeted the United States with an anthrax attack, health care providers and policy makers would need key information - such as knowing the likelihood of an individual becoming infected, how many cases to expect and in what pattern, and how long to give antibiotics - to protect people from the deadly bacteria.

Qualcomm launches Snapdragon Sense ID 3D Fingerprint Technology

Qualcomm Technologies, Inc., a subsidiary of Qualcomm Incorporated, is extending its mobile security leadership with the launch of Qualcomm Snapdragon Sense ID 3D Fingerprint Technology, the mobile industry's first 3D fingerprint authentication technology based on ultrasonic technology.

CCF to continue its million dollar ad campaign against NYC's PSA campaign

Today, the Center for Consumer Freedom (CCF) is running a full-page ad in the New York Times, continuing its million dollar ad campaign against the New York City Department of Health's hyperbolic "Don't drink yourself fat" PSA campaign. The Center will also continue to run ads in the New York Daily News and New York Post that ask New Yorkers, "What's Next?" and "Big Apple or Big Brother?"

ADC Therapeutics, Five Prime sign exclusive license agreement for human antibodies

ADC Therapeutics Sarl, a portfolio company of Auven Therapeutics and the oncology drug development company specializing in proprietary antibody drug conjugates, and Five Prime Therapeutics, Inc., a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today announced an exclusive license agreement for human antibodies directed to an undisclosed target expressed on the surface of various types of cancers.

Celera decreases second-quarter net loss to $6.1 million

Celera Corporation today reported net revenues of $32.6 million for the second quarter of 2010 that ended June 26, 2010, compared to $41.4 million for the prior year quarter. For the second quarter of 2010, Celera reported a net loss of $6.1 million, or $0.07 per share, compared to a net loss of $31.7 million, or $0.39 per share, for the prior year quarter.

Read more Medical News

› Verified 5 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Sean Matchett allows following entities to bill medicare on his behalf.
Entity NameCooper Physician Offices Pa
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1154369510
PECOS PAC ID: 2860396611
Enrollment ID: O20031122000067

News Archive

Mathematical model to help answer critical questions to large-scale anthrax exposure

If terrorists targeted the United States with an anthrax attack, health care providers and policy makers would need key information - such as knowing the likelihood of an individual becoming infected, how many cases to expect and in what pattern, and how long to give antibiotics - to protect people from the deadly bacteria.

Qualcomm launches Snapdragon Sense ID 3D Fingerprint Technology

Qualcomm Technologies, Inc., a subsidiary of Qualcomm Incorporated, is extending its mobile security leadership with the launch of Qualcomm Snapdragon Sense ID 3D Fingerprint Technology, the mobile industry's first 3D fingerprint authentication technology based on ultrasonic technology.

CCF to continue its million dollar ad campaign against NYC's PSA campaign

Today, the Center for Consumer Freedom (CCF) is running a full-page ad in the New York Times, continuing its million dollar ad campaign against the New York City Department of Health's hyperbolic "Don't drink yourself fat" PSA campaign. The Center will also continue to run ads in the New York Daily News and New York Post that ask New Yorkers, "What's Next?" and "Big Apple or Big Brother?"

ADC Therapeutics, Five Prime sign exclusive license agreement for human antibodies

ADC Therapeutics Sarl, a portfolio company of Auven Therapeutics and the oncology drug development company specializing in proprietary antibody drug conjugates, and Five Prime Therapeutics, Inc., a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today announced an exclusive license agreement for human antibodies directed to an undisclosed target expressed on the surface of various types of cancers.

Celera decreases second-quarter net loss to $6.1 million

Celera Corporation today reported net revenues of $32.6 million for the second quarter of 2010 that ended June 26, 2010, compared to $41.4 million for the prior year quarter. For the second quarter of 2010, Celera reported a net loss of $6.1 million, or $0.07 per share, compared to a net loss of $31.7 million, or $0.39 per share, for the prior year quarter.

Read more Medical News

› Verified 5 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Sean Matchett is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Sean Matchett, DO
1 Federal St # 200,
Camden, NJ 08103-1088

Ph: (856) 356-4924
Sean Matchett, DO
1 Cooper Plz,
Camden, NJ 08103-1461

Ph: (856) 342-2000

News Archive

Mathematical model to help answer critical questions to large-scale anthrax exposure

If terrorists targeted the United States with an anthrax attack, health care providers and policy makers would need key information - such as knowing the likelihood of an individual becoming infected, how many cases to expect and in what pattern, and how long to give antibiotics - to protect people from the deadly bacteria.

Qualcomm launches Snapdragon Sense ID 3D Fingerprint Technology

Qualcomm Technologies, Inc., a subsidiary of Qualcomm Incorporated, is extending its mobile security leadership with the launch of Qualcomm Snapdragon Sense ID 3D Fingerprint Technology, the mobile industry's first 3D fingerprint authentication technology based on ultrasonic technology.

CCF to continue its million dollar ad campaign against NYC's PSA campaign

Today, the Center for Consumer Freedom (CCF) is running a full-page ad in the New York Times, continuing its million dollar ad campaign against the New York City Department of Health's hyperbolic "Don't drink yourself fat" PSA campaign. The Center will also continue to run ads in the New York Daily News and New York Post that ask New Yorkers, "What's Next?" and "Big Apple or Big Brother?"

ADC Therapeutics, Five Prime sign exclusive license agreement for human antibodies

ADC Therapeutics Sarl, a portfolio company of Auven Therapeutics and the oncology drug development company specializing in proprietary antibody drug conjugates, and Five Prime Therapeutics, Inc., a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today announced an exclusive license agreement for human antibodies directed to an undisclosed target expressed on the surface of various types of cancers.

Celera decreases second-quarter net loss to $6.1 million

Celera Corporation today reported net revenues of $32.6 million for the second quarter of 2010 that ended June 26, 2010, compared to $41.4 million for the prior year quarter. For the second quarter of 2010, Celera reported a net loss of $6.1 million, or $0.07 per share, compared to a net loss of $31.7 million, or $0.39 per share, for the prior year quarter.

Read more News

› Verified 5 days ago


Hospitalist Doctors in Camden, NJ

Dr. Afaf A. Anter, D.O
Hospitalist
Medicare: Accepting Medicare Assignments
Practice Location: 1 Cooper Plz, Dorrance 222, Camden, NJ 08103
Phone: 856-342-3150    Fax: 856-968-8418
Dr. James Jingren Liu, M.D.
Hospitalist
Medicare: Medicare Enrolled
Practice Location: 1 Cooper Plz, Camden, NJ 08103
Phone: 856-342-2000    
Kalpana Thawani, MD
Hospitalist
Medicare: Accepting Medicare Assignments
Practice Location: 1600 Haddon Ave, Camden, NJ 08103
Phone: 856-757-3700    Fax: 856-668-8479
Pratik S Shah, MD
Hospitalist
Medicare: Accepting Medicare Assignments
Practice Location: 1 Cooper Plz, Camden, NJ 08103
Phone: 856-342-2000    
Dr. Gregory Hilditch, MD
Hospitalist
Medicare: Accepting Medicare Assignments
Practice Location: 1 Cooper Plz, Camden, NJ 08103
Phone: 856-342-2000    
Okebugwu Kamalu, MD
Hospitalist
Medicare: Accepting Medicare Assignments
Practice Location: 1 Cooper Plz, Camden, NJ 08103
Phone: 856-342-2000    
Maher Al-safadi, MD
Hospitalist
Medicare: Accepting Medicare Assignments
Practice Location: 1 Cooper Plz, Camden, NJ 08103
Phone: 856-342-2000    Fax: 856-968-8418

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.